Geography Analysis North America produced USD 15.33 billion sales in 2025, equal to 43.02% of the GLP-1 diabetes drugs market
They are now undergoing extensive research with human trials for potential use as part of the healthy aging process (Guarente et al 2024)
Ziegenhorn AA, Schulte-Herbrggen O, Danker-Hopfe H, Malbranc M, Hartung H, Anders D et al (2007) Serum neurotrophinsa study on the time course and influencing factors in a large old age sample
A recent report suggests drugmakers are quietly trimming sales expectations by 2530 per cent, raising questions about consumer behaviour and long-term adoption
Huadong Pharmaceutical has appealed this ruling but on 31 December 2025, the Supreme Peoples Court in China made a positive decision concerning the intellectual property rights relating to the semaglutide compound patent, and upheld the Beijing IP Court ruling, recognizing the validity of the semaglutide compound patent, until 20 March 2026
Gastrointestinal symptoms Nausea, diarrhoea, vomiting, constipation, abdominal pain, indigestion/dyspepsia, abdominal distension, belching/eructation, gastroenteritis, and gastroesophageal reflux disease Headache Fatigue Dizziness Hypoglycaemia Diabetic retinopathy How to prevent side effects of semaglutide
